Skip to main content
CORDIS - Forschungsergebnisse der EU
CORDIS

NANOTECHNOLOGY-ENABLED DETECTION OF CLINICALLY RELEVANT ANTIBODIES FOR EARLY CANCER DIAGNOSIS AND IMMUNOTHERAPY MONITORING

Projektbeschreibung

Schulung zu Antikörpererkennung mit Nanotechnologie

Durch eine Antikörpererkennung in Körperflüssigkeiten können Informationen über die Exposition einer Person mit verschiedenen Pathogenen generiert werden. Auch die Diagnose von Autoimmun- und anderen Erkrankungen ist so möglich. Doch trotz der breiten Anwendung serologischer Tests mangelt es ihnen an Sensitivität und Spezifizität. Daher ist weitere Forschung nach alternativen Ansätzen erforderlich. Finanziert über die Marie-Skłodowska-Curie-Maßnahmen besteht das übergeordnete Ziel des Projekts Nano-ImmunoEra darin, Biosensoren und diagnostische Instrumente für die Erkennung klinisch relevanter Antikörper mit Nanotechnologie zu entwickeln. Dabei werden hauptsächlich Aktivitäten zur Schulung der nächsten Forschungsgeneration im Bereich Materialforschung, Nanotechnologie, Molekularbiologie und Biosensoren durchgeführt.

Ziel

Nano-ImmunoEra is a research and innovation staff exchange network aiming at the development of innovative biosensors and diagnostic tools for the detection of clinically relevant antibodies. Nano-ImmunoEra will form the next generation of clinically-oriented analytical scientists capable of delivering innovative solutions that will improve the lives of patients, reduce the cost of healthcare and position Europe as a leader in biomedical devices. Since standard laboratory-based methodologies and disposable tests present several analytical limitations, we have selected antibodies as molecular targets of this project because their rapid, sensitive and specific detection in bodily fluids still represent a significant diagnostic challenge. To deliver these goals, we have assembled a highly inter- and multidisciplinary and multicultural team of European as well as strategic non-EU Countries (USA, Switzerland and South Africa) through the collaboration among 7 academic institutions and 2 non-academic partners to enable ultimate impact to the healthcare. The expertise of different and multidisciplinary research teams, comprised of PhD and Postdoctoral as well as experienced researchers from Universities and companies, will endow Nano-ImmunoEra with a strong intersectoral dimension, which is of high importance for a broad and effective impact of the project. In addition, this program involves key participation of junior researchers with exceptional scientific backgrounds and accomplishments, and will provide strong support for the development of their careers. The transfer of knowledge and related training activities aim to provide scientists achieving specific competences in the field of materials sciences, nanotechnology, molecular biology and biosensors.

Koordinator

ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
Netto-EU-Beitrag
€ 128 800,00
Adresse
VIA ZAMBONI 33
40126 Bologna
Italien

Auf der Karte ansehen

Region
Nord-Est Emilia-Romagna Bologna
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
Keine Daten

Beteiligte (4)

Partner (4)